Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome

NCT01237587 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01237587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01237587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2011
Completion date
November 28, 2017
Enrollment
184 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia